NDRG1 and breast cancer: A recent investigation has also confirmed that NDRG1 hyperexpression is pro-oncogenic in aggressive ER-negative breast cancer, with higher nuclear NDRG1 localization being detected in brain metastatic tumors relative to primary breast cancer (20).